New psychoactive substances (NPS) remain a global public health and clinical challenge. Popular NPS include synthetic cannabinoids (SCs). A conceptual metaphorical analysis of user experiences of SCs was conducted in two European countries (Western and Central European). Metaphors are increasingly used to better understand drug user experiences and as medium to inform and guide clinical responses. Semi-structured interviews with 12 SC users were conducted in Hungary (n = 6) and Ireland (n = 6). Thematically segmented texts of SC usage (1) motivation, (2) effects, (3) consequences and (4) the setting were selected. A systematic analysis of conceptual metaphors was conducted on the selected texts. The conceptual target and source domains of the experiences of SC usage (motivation, effects, consequences) were analysed. Four conceptual source domains were found in all of the segmented and analysed narratives of psychological factors (motivations, effects, consequences): change in the vertical perception, perceiving that SC is everywhere, feeling disconnected, recognition of lack of control and identifying the SC as a destroying entity. The conceptual metaphors reflect how users perceive experiences of SC use, the discrepancy between the experience of embodiment and disembodiment. This study provides clinicians with an insight into the experiences of SC motivations, effects and consequences and can be used to inform and guide clinical and therapeutic responses in the support of those recovering from SC dependence.
Arfken, C. L., Owens, D., Madeja, C., & DeAngelis, C. (2014). Exploratory comparative study on the diffusion of synthetic cannabinoids and synthetic cathinones. Journal of Psychoactive Drugs, 46(5), 362–368. PubMed
Barnard, M., Russell, C., McKeganey, N., & Hamilton-Barclay, T. (2017). The highs and lows of NPS/“legal high” use: qualitative views from a UK online survey. Drugs: Education, Prevention and Policy, 24(1), 96–102.
Barratt, M. J., Cakic, V., & Lenton, S. (2013). Patterns of synthetic cannabinoid use in Australia. Drug and Alcohol Review, 32(2), 141–146. PubMed
Bassir Nia, A., Medrano, B., Perkel, C., Galynker, I., & Hurd, Y. L. (2016). Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis. Journal of Psychopharmacology, 30(12), 1321–1330. PubMed
Baumann, M. H., Solis, E., Watterson, L. R., Marusich, J. A., Fantegrossi, W. E., & Wiley, J. L. (2014). Baths salts, spice, and related designer drugs: the science behind the headlines. Journal of Neuroscience, 34(46), 15150–15158. PubMed
Bebarta, V. S., Ramirez, S., & Varney, S. M. (2012). Spice: a new “legal” herbal mixture abused by young active duty military personnel. Substance Abuse, 33(2), 191–194. PubMed
Berry-Cabán, C. S., Ee, J., Ingram, V., Berry, C. E., & Kim, E. H. (2013). Synthetic cannabinoid overdose in a 20-year-old male US soldier. Substance Abuse, 34(1), 70–72. PubMed
Bilgrei, O. R. (2016). From “herbal highs” to the “heroin of cannabis”: exploring the evolving discourse on synthetic cannabinoid use in a Norwegian Internet drug forum. International Journal of Drug Policy, 29, 1–8. PubMed
Bright, S. J., Bishop, B., Kane, R., Marsh, A., & Barratt, M. J. (2013). Kronic hysteria: exploring the intersection between Australian synthetic cannabis legislation, the media, and drug-related harm. International Journal of Drug Policy, 24(3), 231–237. PubMed
Castaneto, M. S., Gorelick, D. A., Desrosiers, N. A., Hartman, R. L., Pirard, S., & Huestis, M. A. (2014). Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug and Alcohol Dependence, 144, 12–41. PubMed
Castellanos, D., Singh, S., Thornton, G., Avila, M., & Moreno, A. (2011). Synthetic cannabinoid use: a case series of adolescents. Journal of Adolescent Health, 49(4), 347–349. PubMed
Corazza, O., Assi, S., Simonato, P., Corkery, J., Bersani, F. S., Demetrovics, Z., et al. (2013). Promoting innovation and excellence to face the rapid diffusion of novel psychoactive substances in the EU: the outcomes of the ReDNet project. Human Psychopharmacology: Clinical and Experimental, 28(4), 317–323.
Dolengevich-Segal, H., Rodríguez-Salgado, B., Gómez-Arnau, J., & Sánchez-Mateos, D. (2017). An approach to the new psychoactive drugs phenomenon. Salud Mental, 40(2), 71–82.
Dresen, S., Kneisel, S., Weinmann, W., Zimmermann, R., & Auwärter, V. (2011). Development and validation of a liquid chromatography–tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples. Journal of Mass Spectrometry, 46(2), 163–171. PubMed
EMCDDA. (2015). New psychoactive substances in Europe. An update from the EU Early Warning System, http://www.emcdda.europa.eu/system/files/publications/65/TD0415135ENN.pdf. Accessed 05 July 2016.
Ernst, L., Schiebel, H. M., Theuring, C., Lindigkeit, R., & Beuerle, T. (2011). Identification and characterization of JWH-122 used as new ingredient in “spice-like” herbal incenses. Forensic Science International, 208(1–3), e31–e35. PubMed
European Monitoring Centre for Drugs and Drug Addiction – EMCDDA. (2009). Thematic paper—understanding the ‘spice’ phenomenon. Office for Official Publications of the European Communities, Luxembourg. Available via DIALOG. http://www.emcdda.europa.eu/attachements.cfm/att_80086_EN_EMCDDA_Understanding%20the%20‘Spice’%20phenomenon_4Update%2020090813.pdf. Accessed 30 May 2017.
Every-Palmer, S. (2010). Warning: legal synthetic cannabinoid-receptor agonists such as JWH-018 may precipitate psychosis in vulnerable individuals. Addiction, 105(10), 1859–1860. PubMed
Every-Palmer, S. (2011). Synthetic cannabinoid JWH-018 and psychosis: an explorative study. Drug and Alcohol Dependence, 117(2–3), 152–157. PubMed
Fantegrossi, W. E., Moran, J. H., Radominska-Pandya, A., & Prather, P. L. (2014). Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ9-THC: mechanism underlying greater toxicity? Life Sciences, 97(1), 45–54. PubMed
Fattore, L. (2016). Synthetic cannabinoids—further evidence supporting the relationship between cannabinoids and psychosis. Biological Psychiatry, 79(7), 539–548. PubMed
Forrester, M. B., Kleinschmidt, K., Schwarz, E., & Young, A. (2011). Synthetic cannabinoid exposures reported to Texas poison centers. Journal of Addictive Diseases, 30(4), 351–358. PubMed
Gerçek, C. (2017). The evaluation of students’ mental images of cigarette through metaphor analysis. Eurasia Journal of Mathematics, Science & Technology Education, 13(1), 105–111.
Gibbs Jr., R. W. (2006). Metaphor interpretation as embodied simulation. Mind & Language, 21(3), 434–458.
Griffiths, P., Sedefov, R., Gallegos, A. N. A., & Lopez, D. (2010). How globalization and market innovation challenge how we think about and respond to drug use:‘Spice’ a case study. Addiction, 105(6), 951–953. PubMed
Gryczynski, J., Johnson, J., & Coyhis, D. (2007). The healing forest metaphor revisited: the seen and “unseen world” of drug use. Substance Use & Misuse, 42(2–3), 475–484.
Gunderson, E. W., Haughey, H. M., Ait-Daoud, N., Joshi, A. S., & Hart, C. L. (2012). “Spice” and “K2” herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans. The American Journal on Addictions, 21(4), 320–326. PubMed
Hermanns-Clausen, M., Kneisel, S., Szabo, B., & Auwärter, V. (2013). Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. Addiction, 108(3), 534–544. PubMed
Hudson, S., Ramsey, J., King, L., Timbers, S., Maynard, S., Dargan, P. I., & Wood, D. M. (2010). Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in “herbal high” products. Journal of Analytical Toxicology, 34(5), 252–260. PubMed
Hurst, D., Loeffler, G., & McLay, R. (2011). Psychosis associated with synthetic cannabinoid agonists: a case series. American Journal of Psychiatry, 168(10), 1119–1119. PubMed
Jellinek, E. M. (1946). Phases in the drinking history of alcoholics. Analysis of a survey conducted by the official organ of alcoholics anonymous (memoirs of the section of studies on alcohol). Quarterly Journal of Studies on Alcohol, 7(1), 1–88. PubMed
Johnson, M., & Lakoff, G. (2002). Why cognitive linguistics requires embodied realism. Cognitive Linguistics, 13(3), 245–264.
Kaló, Z. S., Vida, K., Gogibedasvili, A., Van Hout, M. C., & Rácz, J. (2013). English-Hungarian comparative study on metaphors of intravenous mephedrone use . European Society for Social Drug Research Annual Conference, Stockholm.
Kassai, S., Pintér, J. N., Rácz, J., Erdősi, D., Milibák, R., & Gyarmathy, V. A. (2017b). Using interpretative phenomenological analysis to assess identity formation among users of synthetic cannabinoids. International Journal of Mental Health and Addiction, 15(5), 1047–1054.
Kjellgren, A., & Jonsson, K. (2013). Methoxetamine (MXE) – A phenomenological study of experiences induced by a “Legal High” from the internet. Journal of Psychoactive Drugs, 45(3), 276–286. https://doi.org/10.1080/02791072.2013.803647.
Kikura-Hanajiri, R., Uchiyama, N., & Goda, Y. (2011). Survey of current trends in the abuse of psychotropic substances and plants in Japan. Legal Medicine, 13(3), 109–115. PubMed
Kövecses, Z. (2003). Metaphor and emotion: language, culture, and body in human feeling. Cambridge: Cambridge University Press.
Kovecses, Z. (2010). Metaphor: a practical introduction. New York: Oxford University Press.
Lakoff, G., & Johnson, M. (1980). Metaphors we live by. University of Chicago press.
Lindigkeit, R., Boehme, A., Eiserloh, I., Luebbecke, M., Wiggermann, M., Ernst, L., & Beuerle, T. (2009). Spice: a never ending story? Forensic Science International, 191(1–3), 58–63. PubMed
Macfarlane, V., & Christie, G. (2015). Synthetic cannabinoid withdrawal: a new demand on detoxification services. Drug and Alcohol Review, 34(2), 147–153. PubMed
MacLachlan, M. (2004). Disembodied language. In M. MacLachlan (Ed.), Embodiment. Clinical, critical and cultural perspectives on health and illness (26-27). Open University Press.
Merleau-Ponty, M. (2002). Phenomenology of perception. London: Routledge.
Meshack, A., Peters Jr., R. J., Lin, M. T., Hill, M., Abughosh, S., Essien, E. J., & Savage, C. (2013). The beliefs of teenage male cannabinoid users: a qualitative study. American Journal of Health Studies, 28(3).
Michie, S., Van Stralen, M. M., & West, R. (2011). The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implementation Science, 6(1), 42. PubMed
Moore, D., Fraser, S., Törrönen, J., & Tinghög, M. E. (2015). Sameness and difference: metaphor and politics in the constitution of addiction, social exclusion and gender in Australian and Swedish drug policy. International Journal of Drug Policy, 26(4), 420–428. PubMed
Moser, K. S. (2000). Metaphor analysis in psychology—method, theory, and fields of application. In Forum Qualitative Sozialforschung/Forum: Qualitative Social Research (Vol. 1, no. 2).
Mould, T. J., Oades, L. G., & Crowe, T. P. (2010). The use of metaphor for understanding and managing psychotic experiences: a systematic review. Journal of Mental Health, 19(3), 282–293. PubMed
Müller, H., Sperling, W., Köhrmann, M., Huttner, H. B., Kornhuber, J., & Maler, J. M. (2010). The synthetic cannabinoid spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes. Schizophrenia Research, 118(1), 309–310. PubMed
Nacca, N., Vatti, D., Sullivan, R., Sud, P., Su, M., & Marraffa, J. (2013). The synthetic cannabinoid withdrawal syndrome. Journal of Addiction Medicine, 7(4), 296–298. PubMed
Perlman, D. C., & Jordan, A. E. (2017). To neither target, capture, surveille, nor wage war: on-going need for attention to metaphor theory in care and prevention for people who use drugs. Journal of Addictive Diseases, 36(1), 1–4. PubMed
Rácz J., & Kaló, Z. S. (2009). Metaforák és pszichoaktív anyaghasználat. [Metaphors and psychoactive substance use] Korunk, Retrived from: http://www.korunk.org/?q=node/8&ev=2009&honap=7&cikk=10870. Access date: 2017–07-09.
Rácz, J., Csák, R., Tóth, K. T., Tóth, E., Rozmán, K., & Gyarmathy, V. A. (2016). Veni, vidi, vici: the appearance and dominance of new psychoactive substances among new participants at the largest needle exchange program in Hungary between 2006 and 2014. Drug and Alcohol Dependence, 158, 154–158. PubMed
Reitox National Focal Point. (2016). National Report to the EMCDDA, R.N.F. Point, 2016. http://drogfokuszpont.hu/wp-content/uploads/HU_National_Report_2016.pdf. Accessed 18 Jan 2017.
Roussel, O., Carlin, M. G., Bouvot, X., & Tensorer, L. (2015). The emergence of synthetic cannabinoids in Mayotte. Toxicologie Analytique et Clinique, 27(1), 18–22.
Schifano, F., Corazza, O., Deluca, P., Davey, Z., Di Furia, L., Farre’, M., et al. (2009). Psychoactive drug or mystical incense? Overview of the online available information on spice products. International Journal of Culture and Mental Health, 2(2), 137–144.
Schmitt, R. (2005). Systematic metaphor analysis as a method of qualitative research. The Qualitative Report, 10(2), 358–394.
Schneir, A. B., Cullen, J., & Ly, B. T. (2011). “Spice” girls: synthetic cannabinoid intoxication. The Journal of Emergency Medicine, 40(3), 296–299. PubMed
Shinebourne, P., & Smith, J. A. (2010). The communicative power of metaphors: an analysis and interpretation of metaphors in accounts of the experience of addiction. Psychology and Psychotherapy: Theory, Research and Practice, 83(1), 59–73.
Sobolevsky, T., Prasolov, I., & Rodchenkov, G. (2010). Detection of JWH-018 metabolites in smoking mixture post-administration urine. Forensic Science International, 200(1–3), 141–147. PubMed
Soussan, C., & Kjellgren, A. (2014). The flip side of “spice”: the adverse effects of synthetic cannabinoids as discussed on a Swedish internet forum. Nordic Studies on Alcohol and Drugs, 31(2), 207–220.
Tait, R. J., Caldicott, D., Mountain, D., Hill, S. L., & Lenton, S. (2016). A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clinical Toxicology, 54(1), 1–13. PubMed
Tung, C. K., Chiang, T. P., & Lam, M. (2012). Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong. East Asian Archives of Psychiatry, 22(1), 31–33. PubMed
Tuv, S. S., Strand, M. C., Karinen, R., Øiestad, E. L., Christophersen, A. S., & Vindenes, V. (2012). Effect and occurrence of synthetic cannabinoids. Tidsskrift for den Norske laegeforening: tidsskrift for praktisk medicin, ny raekke, 132(20), 2285–2288.
Uchiyama, N., Kikura-Hanajiri, R., Ogata, J., & Goda, Y. (2010). Chemical analysis of synthetic cannabinoids as designer drugs in herbal products. Forensic Science International, 198(1–3), 31–38. PubMed
UNODC. (2013). The challenge of new psychoactive substances. A Report from the Global SMART Program. Available at: https://www.unodc.org/documents/scientific/NPS_2013_SMART.pdf. Retrived: 22-04-2018.
Van Der Veer, N., & Friday, J. (2011). Persistent psychosis following the use of spice. Schizophrenia Research, 130(1), 285–286. PubMed
Van Hout, M. C. (2017). The dynamic landscape of novel psychoactive substance (NPS) use in Ireland: results from an expert consultation. International Journal of Mental Health and Addiction, 15(5), 985–992.
Van Hout, M. C., & Bingham, T. (2012). “A costly turn on”: patterns of use and perceived consequences of mephedrone based head shop products amongst Irish injectors. International Journal of Drug Policy, 23(3), 188–197. PubMed
Van Hout, M. C., & Brennan, R. (2011a). Plant food for thought: a qualitative study of mephedrone use in Ireland. Drugs: Education, Prevention and Policy, 18(5), 371–381.
Van Hout, M. C., & Brennan, R. (2011b). “Bump and grind”: an exploratory study of mephedrone users’ perceptions of sexuality and sexual risk. Drugs and Alcohol Today, 11(2), 93–103.
Van Hout, M. C., & Brennan, R. (2011c). ‘Heads held high’: an exploratory study of legal highs in pre-legislation Ireland. Journal of Ethnicity in Substance Abuse, 10(3), 256–272. PubMed
Van Hout, M. C., & Brennan, R. (2012). Curiosity killed M-cat: a post-legislative study on mephedrone use in Ireland. Drugs: Education, Prevention and Policy, 19(2), 156–162.
Van Hout, M. C., & Hearne, E. (2017). User experiences of development of dependence on the synthetic cannabinoids, 5f-AKB48 and 5F-PB-22, and subsequent withdrawal syndromes. International Journal of Mental Health and Addiction, 15(3), 565–579.
Vandrey, R., Dunn, K. E., Fry, J. A., & Girling, E. R. (2012). A survey study to characterize use of spice products (synthetic cannabinoids). Drug and Alcohol Dependence, 120(1–3), 238–241. PubMed
Vardakou, I., Pistos, C., & Spiliopoulou, C. (2010). Spice drugs as a new trend: Mode of action, identification and legislation. Toxicology Letters, 197(3), 157–162. PubMed
Vearrier, D., & Osterhoudt, K. C. (2010). A teenager with agitation: higher than she should have climbed. Pediatric Emergency Care, 26(6), 462–465. PubMed
Wallace, B. (2004). Editorial. Addiction Research and Theory, 12(3), 195–199.
Westphal, F., Junge, T., Sönnichsen, F., Rösner, P., & Schäper, J. (2010). Ein neuer Wirkstoff in SPICE-artigen Kräutermischungen: Charakterisierung von JWH-250, seinen methyl-und Trimethylsilylderivaten. [a new compound in herbal mixtures: characterisation of JWH-250, its methyl- and trimethylsilyl-derivatives]. Toxichem Krimtech, 77(1), 8–22.
Winstock, A. R., & Barratt, M. J. (2013). Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample. Drug and Alcohol Dependence, 131(1–2), 106–111. PubMed
Winstock, A., Lynskey, M., Borschmann, R., & Waldron, J. (2015). Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample. Journal of Psychopharmacology, 29(6), 698–703. PubMed
Zawilska, J. B., & Wojcieszak, J. (2014). Spice/K2 drugs—more than innocent substitutes for marijuana. International Journal of Neuropsychopharmacology, 17(3), 509–525. PubMed
Zuba, D., Byrska, B., & Maciow, M. (2011). Comparison of “herbal highs” composition. Analytical and Bioanalytical Chemistry, 400(1), 119–126. PubMed
- Synthetic Cannabinoids (SCs) in Metaphors: a Metaphorical Analysis of User Experiences of Synthetic Cannabinoids in Two Countries
Marie Claire Van Hout
- Springer US
- International Journal of Mental Health and Addiction
Print ISSN: 1557-1874
Elektronische ISSN: 1557-1882